What is the appropriate management of pseudomembranous colitis?

Management of Pseudomembranous Colitis

For pseudomembranous colitis (Clostridioides difficile infection), treatment depends on disease severity: non-severe disease should be treated with oral vancomycin 125 mg four times daily for 10 days, while severe disease requires oral vancomycin 125 mg four times daily combined with IV metronidazole 500 mg three times daily, with early surgical consultation for fulminant cases. 1

Initial Assessment and Severity Classification

First, classify disease severity to guide treatment decisions 1:

Non-severe disease is characterized by:

• Stool frequency <4 times daily
• Absence of severe colitis signs 1

Severe disease includes one or more of:

• Marked leukocytosis (WBC >15 × 10⁹/L) 1
• Rise in serum creatinine (≥50% above baseline or ≥133 μM) 1
• Fever >38.5°C 1
• Hemodynamic instability or septic shock 1
• Signs of ileus (vomiting, absent stool passage) 1
• Decreased albumin (<30 g/L) 1
• Elevated lactate 1
• Colonic wall thickening or distension on imaging 1

Fulminant/complicated disease presents with:

• Toxic megacolon (colon >6 cm diameter with systemic inflammatory response) 1
• Perforation 1
• Peritonitis 1

Medical Management

For Non-Severe Disease (Oral Therapy Possible)

Oral vancomycin 125 mg four times daily for 10 days is now preferred over metronidazole based on updated evidence 1. While older guidelines recommended metronidazole 500 mg three times daily for non-severe disease 1, more recent IDSA/SHEA guidelines favor vancomycin as first-line therapy 1.

For Severe Disease (Oral Therapy Possible)

Oral vancomycin 125 mg four times daily for 10 days (A-I evidence) 1

For Severe Disease When Oral Therapy Impossible

This scenario requires combination therapy 1:

• IV metronidazole 500 mg three times daily PLUS 1
• Intracolonic vancomycin 500 mg in 100 mL normal saline every 4-12 hours (via retention enema) AND/OR 1
• Vancomycin 500 mg four times daily via nasogastric tube 1

The combination approach is critical because IV metronidazole alone achieves poor colonic concentrations when ileus is present 1. Intracolonic vancomycin directly delivers high drug concentrations to the affected mucosa 2.

Tigecycline as Salvage Therapy

IV tigecycline 50 mg twice daily for 14 days can be considered for refractory severe disease, though evidence is limited (B-III recommendation) 1

Critical Supportive Measures

Avoid antiperistaltic agents and opiates (B-II evidence) as they increase risk of toxic megacolon 1

Discontinue the inciting antibiotic immediately when possible 1, 3

Correct fluid and electrolyte abnormalities aggressively 3

Consider vitamin supplementation (vitamins C and B complex) to support intestinal mucosal repair 3

Surgical Management

Indications for Surgery

Early surgical consultation is mandatory for patients with severe disease progressing to systemic toxicity 1. Surgery should be performed for 1:

• Colonic perforation 1
• Systemic inflammation with deteriorating clinical condition not responding to antibiotics 1
• Toxic megacolon 1
• Severe ileus 1

Surgical Options

Total colectomy with end ileostomy remains the standard procedure (89% of cases), with mortality around 33% 1. However, diverting loop ileostomy with antegrade colonic vancomycin lavage is an effective colon-preserving alternative with potentially lower mortality 1. This approach involves creating a loop ileostomy and performing intraoperative colonic lavage with warmed polyethylene glycol followed by vancomycin instillation 1.

Timing of Surgery

Do not delay surgery in patients with 1:

• Age ≥75 years with lactate ≥5 mmol/L 1
• Leukocytosis ≥50 × 10⁹/L 1
• Shock requiring vasopressors 1
• Acute renal failure requiring dialysis 1

Mortality increases significantly when surgery is delayed beyond 48 hours of ICU admission in fulminant cases 1.

Monitoring Treatment Response

Assess response after 3 days of therapy 1:

Treatment response is defined as:

• Decreased stool frequency or improved consistency 1
• No new signs of severe colitis 1

Treatment failure (absence of response) requires escalation to combination therapy or surgical consultation 1

Note that metronidazole may take 3-5 days to show clinical response, so avoid premature treatment changes 1.

Management of Recurrent Disease

First recurrence should be treated the same as initial episode based on severity 1. For multiple recurrences, consider extended vancomycin regimens with tapering doses 4, 3. Five patients (7.5%) in one series experienced recurrence within 2 months, all successfully retreated with extended metronidazole/vancomycin courses 3.

Common Pitfalls to Avoid

Do not use metronidazole monotherapy for severe disease - it has inferior outcomes compared to vancomycin 1

Do not rely on IV antibiotics alone when ileus is present - always add intracolonic or nasogastric vancomycin 1

Do not delay surgical consultation - early involvement of colorectal surgery improves outcomes in severe cases 1

Do not continue the inciting antibiotic - immediate discontinuation is essential 1, 3